Starboard Takes Stake in Consumer Products Maker Kenvue, Sources Say
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Starboard says Kenvue's skin health segment weighing on performance
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)
Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist ...
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
Starboard says Kenvue's skin health segment is weighing on performance
By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...
Kenvue Stock Rallies After Activist Investor Takes Stake
Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...
Kenvue被激进投资者盯上，另一个拆分要来了？
基金投资者Starboard Value在有报道称该投资者已积累大量股份后，可能会推动 $Kenvue Inc (KVUE)$ 剥离其部分或全部“陷入困境的”皮肤、医疗保健和美容（SHB）部门。 鉴于在过去一年半的时间里，SHB部门一直是该股争论的关键领域，预计Starboard将详细说明它希望管理层对该部门做出的改变——我们怀疑这可能涉及剥离该部门的部分或部。
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Kenvue, Inc.: Strong Brand Portfolio and Strategic Initiatives Drive Buy Rating with $27 ...
Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...
Starboard Value据悉已入股消费品公司Kenvue
知情人士透露，对冲基金Starboard Value已入股消费品公司Kenvue，后者于去年上市，前身为强生公司消费者健康业务，公司旗下品牌包括露得清、邦迪、泰诺等。Kenvue的代表尚未就此发表评论。（路透） ...
Kenvue, Inc. Positioned for Growth Amid Strategic Developments and Activist Influence
J.P. Morgan analyst Andrea Faria Teixeira has maintained their bullish stance on KVUE stock, giving a Buy rating on October 15. Andrea Faria ...
Jefferies维持Kenvue股票买入评级
Jefferies重申了对Kenvue Inc (NYSE: KVUE)的信心,维持买入评级,目标价设定为27.00美元。 该公司强调了Kenvue旗下Neutrogena品牌目前正在进行的转型。 Neutrogena品牌以其高消费者认知度而闻名,但与专注于数字营销策略并吸引年轻人群的竞争对手相比表现不佳。 Jefferies的分析师对Neutrogena采用类似于其成功竞争对手的策略表示乐观,认 ...